Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Jubilant Biosys Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12316
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug metabolism and pharmacokinetics, pharma information technology, and discovery informatics services, among others. Jubilant Biosys offers services in therapeutic areas of oncology, metabolic disorders, central nervous system diseases, pain and inflammation. The company offers integrated discovery services spanning across target identification and target validation to lead optimization and preclinical candidates. Jubilant Biosys is headquartered in Bangalore, Karnataka, India.

Jubilant Biosys Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Jubilant Biosys Enters into Agreement with Sanofi-Aventis Deutschland 10
Jubilant Biosys Enters Into Drug Discovery Agreement With Orion 11
Motif BioSciences Enters Into Co-Development Agreement With Jubilant Biosys 12
Jubilant BioSys Enters Into Co-Development Agreement With Mnemosyne Pharma 13
Licensing Agreements 14
Checkpoint Therapeutics Amends its Licensing Agreement with Jubilant Biosys 14
TG Therapeutics Amends its Licensing Agreement with Jubilant Biosys 15
Jubilant Biosys Ltd – Key Competitors 16
Jubilant Biosys Ltd – Key Employees 17
Jubilant Biosys Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jubilant Biosys Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Jubilant Biosys Enters into Agreement with Sanofi-Aventis Deutschland 10
Jubilant Biosys Enters Into Drug Discovery Agreement With Orion 11
Motif BioSciences Enters Into Co-Development Agreement With Jubilant Biosys 12
Jubilant BioSys Enters Into Co-Development Agreement With Mnemosyne Pharma 13
Checkpoint Therapeutics Amends its Licensing Agreement with Jubilant Biosys 14
TG Therapeutics Amends its Licensing Agreement with Jubilant Biosys 15
Jubilant Biosys Ltd, Key Competitors 16
Jubilant Biosys Ltd, Key Employees 17
Jubilant Biosys Ltd, Other Locations 18

List of Figures
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jubilant Biosys Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Dentsply Sirona Inc (XRAY):医療機器:M&Aディール及び事業提携情報
    Summary Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic in …
  • The Interpublic Group of Companies, Inc.:企業の戦略・SWOT・財務情報
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • India Glycols Ltd (INDIAGLYCO):企業の財務・戦略的SWOT分析
    India Glycols Ltd (INDIAGLYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Methanex Corp (MX):企業の財務・戦略的SWOT分析
    Methanex Corp (MX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BlackRock Inc:戦略・SWOT・企業財務分析
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Skanray Technologies Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company that provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surg …
  • Lundin Petroleum AB (LUPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies and matures exploration targets, drill exploration wells, appraise discoveries, and …
  • Corning Incorporated:企業のM&A・事業提携・投資動向
    Corning Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corning Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comp …
  • Mainstream Renewable Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Mainstream Renewable Power Ltd (Mainstream) is the renewable energy developer. The company is involved in developing, financing, constructing, and operating large-scale renewable energy plants. It also develops and builds onshore and offshore wind and solar power plants. The company sells th …
  • Hyundai Heavy Industries Co Ltd (009540):電力:M&Aディール及び事業提携情報
    Summary Hyundai Heavy Industries Co Ltd (HHI) is one of the leading shipbuilding companies in the world. HHI manufactures VLCCs, containerships, P/C ships, LNG carriers, and warships. Its offering also includes combined cycle power plant, thermal power plant, oil and gas processing plant, LNG plant, …
  • Puma SE (PUM):企業の財務・戦略的SWOT分析
    Puma SE (PUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • RBS Wealth Management:企業の戦略・SWOT・財務情報
    RBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • Marquard & Bahls AG:企業の戦略的SWOT分析
    Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Lorain-Medina Rural Electric Cooperative Inc:企業の戦略的SWOT分析
    Lorain-Medina Rural Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Carondelet Health Network-製薬・医療分野:企業M&A・提携分析
    Summary Carondelet Health Network (Carondelet) is a healthcare service organization that serves through its network of hospitals including St. Mary’s Hospital, St. Joseph’s Hospital and Holy Cross Hospital. The organization provides a wide range of medical and treatment services such as neurology or …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆